Our Journey to Breakthrough
NeOnc Technologies Holdings, Inc. was founded in 2008, driven by our founders’ innovative work in drug delivery for Brain and Central Nervous System (CNS) diseases. Our mission is clear: to significantly advance treatment efficacy for patients facing dire prognoses and low survival rates. The core challenge in CNS therapeutics has always been the Blood-Brain Barrier (BBB), a defense mechanism that has historically prevented effective drug delivery.
Our team believes we’ve found the answer, with clinical research consistently validating our findings. We’re aggressively fast-tracking our formulations for FDA approval and ongoing clinical validation, building on our initial successes.
For a comprehensive overview of our latest strategy, download the full presentation deck here (PDF).
Driving Progress with Integrity
Our dedicated research, management, and regulatory teams are deeply committed to rapidly moving our scientific breakthroughs from the lab to the clinic and ultimately into the marketplace. This unwavering focus ensures that treating physicians across the globe gain access to new, vital tools and therapies designed to significantly enhance patient care and improve outcomes for those battling complex brain and CNS diseases.
We not only innovate with scientific rigor but also uphold the highest ethical standards in all our products, services, and communications. This steadfast commitment to integrity is fundamental to fostering enduring trust and delivering substantial value within the medical community, among the patients we serve, our dedicated staff, and our valued stockholders.
Our Mission
We are committed to a world free from the fear of brain cancer. Our mission is to pursue innovative solutions that enhance patient care, bring hope, and extend lives. We aim to transform the standard of care for treating brain and central nervous system diseases through our dedication to research, close collaboration with medical professionals, and personalized care that always places patients and their families at the center of everything we do.
